Sir Cliff Richard has revealed he underwent treatment for prostate cancer over the past year and is now cancer-free. The ...

Resistance to venetoclax (Venclexta® and Venclyxto®, Abbvie / Genentech), the $2.5 billion blockbuster Chronic Lymphocytic ...

Wendy Brooks, a patient with extensive-stage small cell lung cancer, and her husband and care partner, Larry Brooks, sat down ...

Resistance to venetoclax (Venclexta® and Venclyxto®, Abbvie / Genentech), the $2.5 billion blockbuster Chronic Lymphocytic Leukemia (CLL) therapy, is emerging as a ...

Just before one sunrise on the South Carolina coast, a long-forgotten Navy vessel began its final journey to transform from ...

Key Takeaways: Male hypogonadism means your body isn’t making enough testosterone, the hormone that plays a role in drive, ...

Pre-biopsy MRIs can help doctors diagnose and treat prostate cancer more accurately. Here’s when you should get one.

Photon therapy offers strong outcomes in treating oropharyngeal cancers; however, some radiation can reach and damage nearby ...

The FDA approved niraparib and abiraterone acetate (Akeega) in combination with prednisone for treating BRCA2 -mutated ...

Akeega combines niraparib, a PARP inhibitor, and abiraterone acetate, a CYP17 inhibitor, into a single tablet for BRCA2-mutated mCSPC.

The treatment combination was previously approved in BRCA2m-positive patients with metastatic castrate-resistant prostate cancer.